Institute for Clinical Research, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Kumamoto, Japan.
Gastric Cancer. 2012 Jan;15(1):7-14. doi: 10.1007/s10120-011-0052-2. Epub 2011 May 3.
We recently modified our prediction scoring system "Estimation of Physiologic Ability and Surgical Stress" and have designated the current version mE-PASS. This scoring system has been designed to obtain predicted postoperative mortality rates before surgery and this study was performed to assess its usefulness in elective surgery for gastric carcinoma.
We investigated seven variables for mE-PASS and evaluated the postoperative course in 3,449 patients who underwent elective surgery for gastric carcinoma in Japan between August 20, 1987 and April 9, 2007, in order to quantify the predicted in-hospital mortality rates (R). The calibration and discrimination power of R were assessed using the Hosmer-Lemeshow test and the area under the receiver operating characteristic curve (AUC), respectively. The ratios of observed-to-estimated mortality rates (OE ratios) were quantified as a measure of quality.
The overall postoperative morbidity and mortality rates were 19.0 and 2.0%, respectively. R demonstrated good power in calibration (χ(2) value, 12.5; df 8; P = 0.89) as well as discrimination (AUC, 95% confidence intervals: 0.80, 0.75-0.85). The OE ratios between hospitals ranged from 0.44 to 1.8. Overall, the OE ratios seemed to improve with time (OE ratio, 95% confidence intervals: 1.3, 0.73-2.4 for the early period between 1987 and 2000; 1.0, 0.59-1.7 for the middle period between 2001 and 2004; and 0.65, 0.36-1.2 for the late period between 2005 and 2007).
Based on these findings, mE-PASS might be useful for medical decision-making and for assessing the quality of care in elective surgery for gastric carcinoma.
我们最近修改了我们的预测评分系统“生理能力和手术应激估计”,并将当前版本命名为 mE-PASS。该评分系统旨在术前获得预测术后死亡率,并进行了这项研究以评估其在胃癌择期手术中的作用。
我们调查了 mE-PASS 的七个变量,并评估了 1987 年 8 月 20 日至 2007 年 4 月 9 日期间在日本接受胃癌择期手术的 3449 例患者的术后病程,以量化预测住院死亡率(R)。使用 Hosmer-Lemeshow 检验和受试者工作特征曲线下面积(AUC)评估 R 的校准和区分能力。观察到的与估计死亡率的比值(OE 比值)被量化为质量的度量。
总的术后发病率和死亡率分别为 19.0%和 2.0%。R 在校准方面具有良好的能力(χ²值为 12.5;df 8;P = 0.89)以及区分能力(AUC,95%置信区间:0.80,0.75-0.85)。医院之间的 OE 比值范围为 0.44 至 1.8。总体而言,OE 比值似乎随时间改善(OE 比值,95%置信区间:1987 年至 2000 年早期为 1.3,0.73-2.4;2001 年至 2004 年中期为 1.0,0.59-1.7;2005 年至 2007 年晚期为 0.65,0.36-1.2)。
基于这些发现,mE-PASS 可能有助于医疗决策,并评估胃癌择期手术的护理质量。